This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

Sandbox Reserved 1176

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 18:32, 1 April 2016

This Sandbox is Reserved from Jan 11 through August 12, 2016 for use in the course CH462 Central Metabolism taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1160 through Sandbox Reserved 1184.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Rattus norevegicus NTSR1

An interactive view of the class A GPCR, NTSR1. This protein gets its activity from binding to its 13 amino acid ligand, NTS

Drag the structure with the mouse to rotate

This is a default text for your page Allison Cotter/Sandbox 1. Click above on edit this page to modify. Be careful with the < and > signs.

You may include any references to papers as in: the use of JSmol in Proteopedia ^[1] or to the article describing Jmol ^[2] to the rescue.

 ^[3] ^[4] ^[5]

1 Introduction
2 Structure
3 Biological Relevance
4 Structural Research
- 4.1 Active-Like State
- 4.2 Active State

Introduction

Figure 1.Top view of NTSR1 protein interacting with NTS ligand

Neurotensin receptor 1 (NTSR1) is a G-protein coupled receptor (GPCR) that binds to the 13 amino acid peptide, neurotensin^[6]. Studies determining the structure of NTSR1 crystallized the GPCR bound with the C-terminus of its tridecapeptide ligand, because it has a higher potency and efficacy than its full-length counterpart^[6]. NTSR1 is a class A GPCR, and like all G-proteins, consists 7 transmembrane helices. Class A GPCRs bind their ligands within the transmembrane core, and this is seen in NTSR1. Along with the ligand binding pocket at the top of the protein, NTSR1 also contains an allosteric Na+ ion binding pocket underneath^[7]. NTS binds to NTSR1, leading to a conformational change of the protein and modulation of second messengers^[7]. NTS has been shown to have a variety of biological activities including a role in the leptin signalling pathways ^[5], tumor growth ^[3], and dopamine regulation ^[4]. The majority of effects of NTS are mediated through NTSR1^[6]. Research of the structure of NTSR1 has focused on the differences between its active and active-like states.

Structure

Ligand Binding Pocket

Near the top of the protein is the This pocket is comprised of several key amino acid resides. The first reside is a Phenylalanine at position F358. The purpose of this amino acid is to take part in a network of hydrophobic stacking interactions. These interactions stabilize the Y324 and W321 residues. These are crucial interactions because the Y324 is the amino acid residue that directly interacts with the via Van der Waals interactions . Without the hydrophobic stacking interactions that are facilitated by the F358 this binding interaction would not occur. The W321 residue also partakes in these stacking interactions. The W321 serves as the boundary between the ligand binding pocket and the sodium binding pocket.

Na+ Binding Pocket

Figure 2. Residues of collapsed sodium binding pocket

, which is positioned at the bottom of the , sets the top of the . The Na+ ion binding pocket acts as a negative allosteric site for G protein activity. When Na+ enters the Na+ ion binding pocket, it coordinates with Asp95, Gln131, Ser135, and Asp113. This decreases the activity of the protein. When the G protein is in its active state, the Na+ ion binding pocket is collapsed, preventing the regulation of protein activity through a Na+ ion. In this case, the Na+ ion is unable to be coordinated by a salt bridge to Asp113. The side chain atoms of Asp113 form a hydrogen bond network with Thr156, Ser361, Ser362, and Gln365 instead, which prevents the coordination of a Na+ ion.

Neurotensin

is a 13 amino acid peptide that is found in both nervous and peripheral tissues. It functions as a hormone and a neurotransmitter by activating as the ligand for the G-protein coupled receptor NTSR1.

Biological Relevance

Leptin Research

A study was done by Liang Y. et al.to analyze the effects that being NTSR1 deficient had on mice. The results demonstrated that mice who were NTSR1 deficient were not able to receive a satiety signal.This resulted in the mice to continuing to eat as long as food was present, leading to significant weight gain. This is due to the fact that NTSR1 is involved in a signaling pathway that regulates Leptin and therefore food intake. Without sufficient NTSR1 this pathway is interrupted. ^[5]

Cancer Studies

It has been shown that some tumor cells can secrete and express Neurotensin and Neurotensin receptors themselves suggetsing that autocrine, endocrine and paracrine regulation by Neurotensin are possible. This leads to aggressive growth and possibly tumor development. A study was done that demonstrated that injecting animals with Neurotensin increased tumor growth and size, while injecting them with Neurotensin antagonist decreased tumor growth ^[3].It is believed that Neurotensin regulation may be used in future cancer treatment techniques.

Schizophrenia Research

The dopamine hypothesis states that having hyperdopamine levels may lead to schizophrenic symptoms. It has been shown that NTSR1 caused a blockade which inhibited firing in dopaminergic cells. It is believed that NTSR1 could therefore be used as a therapeutic for treating schizophrenia.Although this research is promising, the secondary effects were too extreme and the trial was discontinued.This is a pathway where NTSR1 research is focused on that could lead to ground breaking advances in treating schizophrenia.^[4]

Structural Research

Studies have been done to decipher the structure of NTSR1. Since wild type NTSR1 is unstable in detergent solution, select residues in the protein were mutated for stabilization. None of these residues are in the NTS binding pocket.

Active-Like State

Originally, six different amino acids were mutated for thermostabilization in detergent solution. These mutations were A86L, E166A, G215A, L310A, F358A, and V360A. This protein was found to have NTS affinity similar to that of wild tpye NTSR1, and was named . Along with this, the Na+ ion binding pocket was found to be collapsed in this protein. However, studies found that NTSR1-GW5 did not have G-protein activity.

Active State

After determining as only active-like, research was conducted to determine the structure of NTSR1 with catalytic nucleotide exchange. In order to do so, three of the six mutations were reverted back, and these three residues were selected on the basis of their location. The reversion of E166A, L310A, and F358A led to NTSR1 with G-protein activity at almost wild-type level. This protein was named, , and indicated that the amino acid residues E166, L310, and F358 play significant roles in the activity of NTSR1.

L310

Image:Final L310.png

Figure 3. Critical residue interactions of L310 in the active state

This residue is crucial for interactions with the G alpha subunit by interacting with the R167. When it was mutated to an alanine, because it was small it allowed R167 to form a stabilizing hydrogen bonding network with N 257, S164 and G306. This network oriented R167 in a position that was unfavorable for contacting the G alpha subunit. When it was converted back to leucine the hydrogen-bonding network was sterically unfavorable. The R167 resides is then able to interact with the G alpha subunit.

F358

The residue plays an important role in a network of . It is through these interactions that F358 is able to stabilize both the W321 and Y324. The Y324 reside is the amino acid that directly interacts with the NTS ligand allowing binding of NTS to NTSR1. When the F358 residue was mutated to an alanine the hydrophobic stacking interactions were interrupted. This negatively influenced bonding with the NTS ligand. These interactions also maintain proper orientation of W321 which is the dividing residue between the Sodium binding pocket and the ligand binding pocket.

E166

Although the role of E166 in G-protein activity is not quite as clear as it is for L310 or F358, mutating this residue to an alanine significantly reduced catalytic nucleotide exchange. E166 is part of a D/ERY motif that is highly conserved in class A GPCRs. This motif includes R167, which is positioned by L310, as mentioned. In order to hypothesize a role for E166, Krumm et al looked at other class A GPCRs. In the active M2 receptor, the acidic amino acid is stabilized by a hydrogen bond with N58, and this N58 plays a direct role in stabilization of the G protein. The interaction of E166 in NTSR1 has a similar interaction with V102 and T101, along with a weak interaction with H105. The researchers then looked at the β2AR receptor and found Y141 positioned intracellular helix 2, and this interaction was linked with the D/ERY motif. This was determined an essential interaction for G-protein activity, and M181 may cause an equivalent interaction in NTSR1. E166 and the residues it is hypothesized to interact with are shown below.

Image:E166 for Proteopedia page.png

Figure 4. View of residue interactions around E166 of the conserve D/ERY motif

References

↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
↑ ^3.0 ^3.1 ^3.2 Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides. 2006 Oct;27(10):2445-60. Epub 2006 Aug 2. PMID:16887236 doi:http://dx.doi.org/10.1016/j.peptides.2006.04.030
↑ ^4.0 ^4.1 ^4.2 Griebel G, Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov. 2012 May 18;11(6):462-78. doi: 10.1038/nrd3702. PMID:22596253 doi:http://dx.doi.org/10.1038/nrd3702
↑ ^5.0 ^5.1 ^5.2 Liang Y, Boules M, Li Z, Williams K, Miura T, Oliveros A, Richelson E. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology. 2010 Jun;58(8):1199-205. doi:, 10.1016/j.neuropharm.2010.02.015. Epub 2010 Mar 6. PMID:20211191 doi:http://dx.doi.org/10.1016/j.neuropharm.2010.02.015
↑ ^6.0 ^6.1 ^6.2 White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, Grisshammer R. Structure of the agonist-bound neurotensin receptor. Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10. PMID:23051748 doi:http://dx.doi.org/10.1038/nature11558
↑ ^7.0 ^7.1 Krumm BE, White JF, Shah P, Grisshammer R. Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun. 2015 Jul 24;6:7895. doi: 10.1038/ncomms8895. PMID:26205105 doi:http://dx.doi.org/10.1038/ncomms8895

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1176"

@@ Line 4: / Line 4: @@
 This is a default text for your page '''Allison Cotter/Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
 You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
-  <ref>PMID:16887236</ref> <ref name="Schizophrenia">PMID:22596253</ref> <ref name="Mice">PMID: 20211191</ref>
+  <ref name="cancer">PMID:16887236</ref> <ref name="Schizophrenia">PMID:22596253</ref> <ref name="Mice">PMID: 20211191</ref>
 ==Introduction==
 [[Image:surfaceprotein.png |300 px|below|thumb|Figure 1.Top view of NTSR1 protein interacting with NTS ligand]]
-Neurotensin receptor 1 (NTSR1) is a G-protein coupled receptor (GPCR) that binds to the 13 amino acid peptide, neurotensin<ref name="SONT">PMID:23051748</ref>. Studies determining the structure of NTSR1 crystallized the GPCR bound with the C-terminus of its tridecapeptide ligand, <scene name='72/721548/Neurotensin/3'>NTS(8-13)</scene> because it has a higher potency and efficacy than its full-length counterpart<ref name="SONT"/>. NTSR1 is a class A GPCR, and like all G-proteins, consists 7 transmembrane helices. Class A GPCRs bind their ligands within the transmembrane core, and this is seen in NTSR1. Along with the ligand binding pocket at the top of the protein, NTSR1 also contains an allosteric Na+ ion binding pocket underneath<ref name="SPGP">PMID:26205105</ref>. NTS binds to NTSR1, leading to a conformational change of the protein and modulation of second messengers<ref name="SPGP"/>. NTS has been shown to have a variety of biological activities including a role in the leptin signalling pathways, tumor growth, and dopamine regulation. The majority of effects of NTS are mediated through NTSR1<ref name="SONT"/>. Research of the structure of NTSR1 has focused on the differences between its active and active-like states.
+Neurotensin receptor 1 (NTSR1) is a G-protein coupled receptor (GPCR) that binds to the 13 amino acid peptide, neurotensin<ref name="SONT">PMID:23051748</ref>. Studies determining the structure of NTSR1 crystallized the GPCR bound with the C-terminus of its tridecapeptide ligand, <scene name='72/721548/Neurotensin/3'>NTS(8-13)</scene> because it has a higher potency and efficacy than its full-length counterpart<ref name="SONT"/>. NTSR1 is a class A GPCR, and like all G-proteins, consists 7 transmembrane helices. Class A GPCRs bind their ligands within the transmembrane core, and this is seen in NTSR1. Along with the ligand binding pocket at the top of the protein, NTSR1 also contains an allosteric Na+ ion binding pocket underneath<ref name="SPGP">PMID:26205105</ref>. NTS binds to NTSR1, leading to a conformational change of the protein and modulation of second messengers<ref name="SPGP"/>. NTS has been shown to have a variety of biological activities including a role in the leptin signalling pathways <ref name="Mice"/>, tumor growth <ref name="cancer"/>, and dopamine regulation <ref name="Schizophrenia"/>. The majority of effects of NTS are mediated through NTSR1<ref name="SONT"/>. Research of the structure of NTSR1 has focused on the differences between its active and active-like states.
 == Structure ==
@@ Line 30: / Line 30: @@
 A study was done by Liang Y. et al.to analyze the effects that being NTSR1 deficient had on mice. The results demonstrated that mice who were NTSR1 deficient were not able to receive a satiety signal.This resulted in the mice to continuing to eat as long as food was present, leading to significant weight gain. This is due to the fact that NTSR1 is involved in a signaling pathway that regulates '''[https://en.wikipedia.org/wiki/Leptin Leptin]''' and therefore food intake. Without sufficient NTSR1 this pathway is interrupted. <ref name="Mice"/>
 ===Cancer Studies===
-It has been shown that some tumor cells can secrete and express Neurotensin and Neurotensin receptors themselves suggetsing that autocrine, endocrine and paracrine regulation by Neurotensin are possible. This leads to aggressive growth and possibly tumor development. A study was done that demonstrated that injecting animals with Neurotensin increased tumor growth and size, while injecting them with Neurotensin antagonist decreased tumor growth.It is believed that Neurotensin regulation may be used in future cancer treatment techniques.
+It has been shown that some tumor cells can secrete and express Neurotensin and Neurotensin receptors themselves suggetsing that autocrine, endocrine and paracrine regulation by Neurotensin are possible. This leads to aggressive growth and possibly tumor development. A study was done that demonstrated that injecting animals with Neurotensin increased tumor growth and size, while injecting them with Neurotensin antagonist decreased tumor growth <ref name="cancer"/>.It is believed that Neurotensin regulation may be used in future cancer treatment techniques.
 ===Schizophrenia Research===